Health Care Company Coherus BioSciences Announces Merger With Surface Oncology
Health Care Company Coherus BioSciences Announces Merger With Surface Oncology
Coherus BioSciences (NASDAQ:CHRS) has announced a merger with Surface Oncology (NASDAQ:SURF) that is expected to be completed in Q3 of 2023.
Coherus 生物科學 納斯達克股票代碼：CHRS）宣佈與合併 表面腫瘤學 （納斯達克股票代碼：SURF）預計將於2023年第三季度完工。
Under the terms of the agreement, Coherus BioSciences has agreed to give Surface Oncology $40.00 million in in exchange for SURF stock. Currently, neither company has disclosed whether the paymentwill be in cash or in stock.
根據協議條款，Coherus BioSciences已同意向Surface Oncology提供4,000萬美元，以換取SURF股票。目前，兩家公司都沒有透露這筆款項是現金還是股票。
About The Companies Involved
關於所涉公司
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an innovative immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. Toripalimab is being evaluated in pivotal clinical trials for the treatment of cancers of the lung, breast, liver, skin, kidney, stomach, esophagus, and bladder.
Coherus BioSciences Inc是一家處於商業階段的生物製藥公司，正在建立創新的免疫腫瘤學特許經營權，資金來自其經美國食品藥品管理局批准的多元化療法組合產生的現金。Toripalimab正在對治療肺癌、乳腺癌、肝癌、皮膚癌、腎癌、胃癌、食道癌和膀胱癌的關鍵臨床試驗進行評估。
Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors in the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses.
Surface Oncology Inc是一家處於臨床階段的免疫腫瘤學公司。它正在開發新的療法，改變腫瘤微環境中腫瘤內部和周圍的空間，爲支持和維持抗腫瘤免疫反應創造條件。
How A Merger Works
合併是如何運作的
A merger happens when a company combines operations with another company. In practice, one company will buy the other company's stock in exchange for its own stock. In some cases, cash is used to pay for the company's stock but usually the companies agree to a stock-for-stock transaction.
當一家公司與另一家公司合併業務時，就會發生合併。實際上，一家公司將購買另一家公司的股票以換取自己的股票。在某些情況下，現金用於支付公司的股票，但通常公司同意以股換股的交易。
Due to the exchange and acquisition of stock, a merger is similar to an acquisition. This is why the two terms are commonly grouped together as mergers and acquisitions (M&A). However, in a merger, the leadership & operations of both companies usually change dramatically, while during an acquisition this is less likely to happen.
由於股票的交換和收購，合併類似於收購。這就是爲甚麼這兩個術語通常歸爲合併和收購（M&A）的原因。但是，在合併中，兩家公司的領導層和運營通常會發生巨大變化，而在收購期間，這種情況發生的可能性較小。
Make sure to follow our mergers & acquisitions calendar to stay-up-to-date on the most recent M&A deals.
一定要 關注我們的併購日曆 隨時瞭解最新的併購交易。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。